nodes	percent_of_prediction	percent_of_DWPC	metapath
Alpha-Linolenic Acid—Azelaic Acid—Vorinostat—hematologic cancer	0.675	1	CrCrCtD
Alpha-Linolenic Acid—FABP3—hematopoietic system—hematologic cancer	0.00741	0.0864	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—hematopoietic system—hematologic cancer	0.00661	0.077	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—hematopoietic system—hematologic cancer	0.00661	0.077	CbGeAlD
Alpha-Linolenic Acid—FABP3—gonad—hematologic cancer	0.00564	0.0657	CbGeAlD
Alpha-Linolenic Acid—FADS2—hematopoietic system—hematologic cancer	0.00562	0.0655	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—blood—hematologic cancer	0.00438	0.051	CbGeAlD
Alpha-Linolenic Acid—FABP3—lung—hematologic cancer	0.00431	0.0502	CbGeAlD
Alpha-Linolenic Acid—FADS2—gonad—hematologic cancer	0.00427	0.0498	CbGeAlD
Alpha-Linolenic Acid—FABP3—testis—hematologic cancer	0.00406	0.0474	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—lung—hematologic cancer	0.00384	0.0447	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—testis—hematologic cancer	0.00362	0.0422	CbGeAlD
Alpha-Linolenic Acid—TRPV1—gonad—hematologic cancer	0.00335	0.0391	CbGeAlD
Alpha-Linolenic Acid—FADS2—lung—hematologic cancer	0.00326	0.038	CbGeAlD
Alpha-Linolenic Acid—FADS2—testis—hematologic cancer	0.00308	0.0359	CbGeAlD
Alpha-Linolenic Acid—FADS1—blood—hematologic cancer	0.00292	0.034	CbGeAlD
Alpha-Linolenic Acid—FADS1—bone marrow—hematologic cancer	0.00283	0.0329	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—lymph node—hematologic cancer	0.00262	0.0306	CbGeAlD
Alpha-Linolenic Acid—FADS1—lung—hematologic cancer	0.00256	0.0298	CbGeAlD
Alpha-Linolenic Acid—FADS1—testis—hematologic cancer	0.00242	0.0282	CbGeAlD
Alpha-Linolenic Acid—TRPV1—testis—hematologic cancer	0.00242	0.0282	CbGeAlD
Alpha-Linolenic Acid—FADS2—lymph node—hematologic cancer	0.00223	0.026	CbGeAlD
Alpha-Linolenic Acid—FADS1—lymph node—hematologic cancer	0.00175	0.0204	CbGeAlD
Alpha-Linolenic Acid—Dermatitis—Methoxsalen—hematologic cancer	0.000344	0.00263	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Nilotinib—hematologic cancer	0.000344	0.00262	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Thalidomide—hematologic cancer	0.000343	0.00262	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Imatinib—hematologic cancer	0.000342	0.00261	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Nilotinib—hematologic cancer	0.00034	0.0026	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Imatinib—hematologic cancer	0.000338	0.00258	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Mercaptopurine—hematologic cancer	0.000337	0.00258	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Carmustine—hematologic cancer	0.000337	0.00257	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Cladribine—hematologic cancer	0.000336	0.00256	CcSEcCtD
Alpha-Linolenic Acid—Rash—Mercaptopurine—hematologic cancer	0.000335	0.00255	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Mercaptopurine—hematologic cancer	0.000334	0.00255	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Alitretinoin—hematologic cancer	0.000334	0.00255	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Clofarabine—hematologic cancer	0.000333	0.00254	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Daunorubicin—hematologic cancer	0.000333	0.00254	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Cladribine—hematologic cancer	0.000332	0.00254	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Pentostatin—hematologic cancer	0.000331	0.00253	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Anagrelide—hematologic cancer	0.000331	0.00253	CcSEcCtD
Alpha-Linolenic Acid—Rash—Daunorubicin—hematologic cancer	0.00033	0.00252	CcSEcCtD
Alpha-Linolenic Acid—Rash—Clofarabine—hematologic cancer	0.00033	0.00252	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Ifosfamide—hematologic cancer	0.00033	0.00252	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Daunorubicin—hematologic cancer	0.00033	0.00252	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Clofarabine—hematologic cancer	0.00033	0.00252	CcSEcCtD
Alpha-Linolenic Acid—Rash—Pentostatin—hematologic cancer	0.000328	0.00251	CcSEcCtD
Alpha-Linolenic Acid—Rash—Anagrelide—hematologic cancer	0.000328	0.00251	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Anagrelide—hematologic cancer	0.000328	0.00251	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Pentostatin—hematologic cancer	0.000328	0.00251	CcSEcCtD
Alpha-Linolenic Acid—Eructation—Epirubicin—hematologic cancer	0.000328	0.00251	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Busulfan—hematologic cancer	0.00032	0.00245	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Idarubicin—hematologic cancer	0.000319	0.00244	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Vinblastine—hematologic cancer	0.000319	0.00243	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Bortezomib—hematologic cancer	0.000317	0.00242	CcSEcCtD
Alpha-Linolenic Acid—Rash—Idarubicin—hematologic cancer	0.000317	0.00242	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Idarubicin—hematologic cancer	0.000316	0.00242	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Bleomycin—hematologic cancer	0.000315	0.0024	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Melphalan—hematologic cancer	0.000312	0.00238	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Procarbazine—hematologic cancer	0.000311	0.00237	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Teniposide—hematologic cancer	0.000311	0.00237	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Vinorelbine—hematologic cancer	0.00031	0.00237	CcSEcCtD
Alpha-Linolenic Acid—Rash—Teniposide—hematologic cancer	0.000308	0.00235	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Teniposide—hematologic cancer	0.000308	0.00235	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Mitoxantrone—hematologic cancer	0.000307	0.00234	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Melphalan—hematologic cancer	0.000306	0.00234	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Dasatinib—hematologic cancer	0.000305	0.00233	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Bexarotene—hematologic cancer	0.000305	0.00233	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Fludarabine—hematologic cancer	0.000304	0.00232	CcSEcCtD
Alpha-Linolenic Acid—Eructation—Doxorubicin—hematologic cancer	0.000304	0.00232	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Lenalidomide—hematologic cancer	0.000304	0.00232	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Hydroxyurea—hematologic cancer	0.000299	0.00229	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Lenalidomide—hematologic cancer	0.000298	0.00227	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Lenalidomide—hematologic cancer	0.000295	0.00225	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Hydroxyurea—hematologic cancer	0.000294	0.00224	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Hydroxyurea—hematologic cancer	0.000291	0.00222	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Busulfan—hematologic cancer	0.000288	0.0022	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Chlorambucil—hematologic cancer	0.000288	0.0022	CcSEcCtD
Alpha-Linolenic Acid—Rash—Busulfan—hematologic cancer	0.000286	0.00218	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Busulfan—hematologic cancer	0.000285	0.00218	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Cisplatin—hematologic cancer	0.000284	0.00217	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Nilotinib—hematologic cancer	0.000282	0.00215	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Imatinib—hematologic cancer	0.00028	0.00214	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Procarbazine—hematologic cancer	0.000279	0.00213	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Bortezomib—hematologic cancer	0.000279	0.00213	CcSEcCtD
Alpha-Linolenic Acid—Rash—Procarbazine—hematologic cancer	0.000277	0.00212	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Procarbazine—hematologic cancer	0.000277	0.00211	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Cladribine—hematologic cancer	0.000275	0.0021	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Bortezomib—hematologic cancer	0.000274	0.00209	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Bexarotene—hematologic cancer	0.000274	0.00209	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Dasatinib—hematologic cancer	0.000274	0.00209	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Prednisone—hematologic cancer	0.000273	0.00209	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Fludarabine—hematologic cancer	0.000273	0.00209	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000272	0.00208	CcSEcCtD
Alpha-Linolenic Acid—Rash—Dasatinib—hematologic cancer	0.000272	0.00207	CcSEcCtD
Alpha-Linolenic Acid—Rash—Bexarotene—hematologic cancer	0.000272	0.00207	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Bortezomib—hematologic cancer	0.000271	0.00207	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Dasatinib—hematologic cancer	0.000271	0.00207	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Bexarotene—hematologic cancer	0.000271	0.00207	CcSEcCtD
Alpha-Linolenic Acid—Rash—Fludarabine—hematologic cancer	0.000271	0.00207	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Fludarabine—hematologic cancer	0.000271	0.00207	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000269	0.00206	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Vinorelbine—hematologic cancer	0.000268	0.00204	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Vinorelbine—hematologic cancer	0.000265	0.00202	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Vincristine—hematologic cancer	0.000262	0.002	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Thiotepa—hematologic cancer	0.000261	0.00199	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Chlorambucil—hematologic cancer	0.000259	0.00198	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Irinotecan—hematologic cancer	0.000256	0.00195	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000256	0.00195	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.000256	0.00195	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Etoposide—hematologic cancer	0.000255	0.00195	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Thiotepa—hematologic cancer	0.000253	0.00193	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Nilotinib—hematologic cancer	0.000253	0.00193	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Thalidomide—hematologic cancer	0.000252	0.00192	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Imatinib—hematologic cancer	0.000252	0.00192	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Melphalan—hematologic cancer	0.000251	0.00192	CcSEcCtD
Alpha-Linolenic Acid—Rash—Nilotinib—hematologic cancer	0.000251	0.00192	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Nilotinib—hematologic cancer	0.000251	0.00191	CcSEcCtD
Alpha-Linolenic Acid—Rash—Imatinib—hematologic cancer	0.00025	0.0019	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Imatinib—hematologic cancer	0.000249	0.0019	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000249	0.0019	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Cladribine—hematologic cancer	0.000247	0.00189	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000247	0.00189	CcSEcCtD
Alpha-Linolenic Acid—Rash—Cladribine—hematologic cancer	0.000245	0.00187	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Cladribine—hematologic cancer	0.000245	0.00187	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Thalidomide—hematologic cancer	0.000245	0.00187	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Lenalidomide—hematologic cancer	0.000244	0.00186	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Alitretinoin—hematologic cancer	0.00024	0.00183	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000237	0.00181	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Vinblastine—hematologic cancer	0.000237	0.00181	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000235	0.0018	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Carmustine—hematologic cancer	0.000235	0.00179	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Alitretinoin—hematologic cancer	0.000233	0.00178	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000232	0.00177	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Cisplatin—hematologic cancer	0.000232	0.00177	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Triamcinolone—hematologic cancer	0.000231	0.00177	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Ifosfamide—hematologic cancer	0.00023	0.00176	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000227	0.00173	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Melphalan—hematologic cancer	0.000226	0.00172	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Mitoxantrone—hematologic cancer	0.000225	0.00172	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Irinotecan—hematologic cancer	0.000225	0.00172	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Bortezomib—hematologic cancer	0.000225	0.00171	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Vincristine—hematologic cancer	0.000224	0.00171	CcSEcCtD
Alpha-Linolenic Acid—Rash—Melphalan—hematologic cancer	0.000224	0.00171	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Melphalan—hematologic cancer	0.000223	0.00171	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Bleomycin—hematologic cancer	0.000223	0.0017	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000221	0.00168	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Lenalidomide—hematologic cancer	0.000219	0.00167	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Vinorelbine—hematologic cancer	0.000219	0.00167	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Irinotecan—hematologic cancer	0.000219	0.00167	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Mitoxantrone—hematologic cancer	0.000219	0.00167	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Epirubicin—hematologic cancer	0.000218	0.00167	CcSEcCtD
Alpha-Linolenic Acid—Rash—Lenalidomide—hematologic cancer	0.000217	0.00166	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Lenalidomide—hematologic cancer	0.000217	0.00166	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Hydroxyurea—hematologic cancer	0.000216	0.00165	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000215	0.00164	CcSEcCtD
Alpha-Linolenic Acid—Rash—Hydroxyurea—hematologic cancer	0.000214	0.00164	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Hydroxyurea—hematologic cancer	0.000214	0.00164	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Epirubicin—hematologic cancer	0.000214	0.00163	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Gemcitabine—hematologic cancer	0.000213	0.00163	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Etoposide—hematologic cancer	0.000213	0.00162	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Prednisolone—hematologic cancer	0.00021	0.0016	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Thiotepa—hematologic cancer	0.000209	0.0016	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Thalidomide—hematologic cancer	0.000203	0.00155	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Doxorubicin—hematologic cancer	0.000202	0.00154	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Bortezomib—hematologic cancer	0.000202	0.00154	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.0002	0.00153	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Bleomycin—hematologic cancer	0.0002	0.00153	CcSEcCtD
Alpha-Linolenic Acid—Rash—Bortezomib—hematologic cancer	0.0002	0.00153	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Bortezomib—hematologic cancer	0.0002	0.00153	CcSEcCtD
Alpha-Linolenic Acid—Rash—Bleomycin—hematologic cancer	0.000199	0.00152	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Bleomycin—hematologic cancer	0.000198	0.00151	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	0.000198	0.00151	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Vinorelbine—hematologic cancer	0.000197	0.0015	CcSEcCtD
Alpha-Linolenic Acid—Rash—Vinorelbine—hematologic cancer	0.000195	0.00149	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Vinorelbine—hematologic cancer	0.000195	0.00149	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000193	0.00147	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Alitretinoin—hematologic cancer	0.000193	0.00147	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Ifosfamide—hematologic cancer	0.00019	0.00145	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Thiotepa—hematologic cancer	0.000188	0.00144	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Prednisone—hematologic cancer	0.000187	0.00143	CcSEcCtD
Alpha-Linolenic Acid—Rash—Thiotepa—hematologic cancer	0.000187	0.00142	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Thiotepa—hematologic cancer	0.000186	0.00142	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000184	0.0014	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Thalidomide—hematologic cancer	0.000182	0.00139	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Etoposide—hematologic cancer	0.000182	0.00139	CcSEcCtD
Alpha-Linolenic Acid—Rash—Thalidomide—hematologic cancer	0.00018	0.00138	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Thalidomide—hematologic cancer	0.00018	0.00138	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Gemcitabine—hematologic cancer	0.000176	0.00134	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000175	0.00134	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Betamethasone—hematologic cancer	0.000175	0.00134	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Carmustine—hematologic cancer	0.000175	0.00133	CcSEcCtD
Alpha-Linolenic Acid—Rash—Carmustine—hematologic cancer	0.000173	0.00132	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Carmustine—hematologic cancer	0.000173	0.00132	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Alitretinoin—hematologic cancer	0.000173	0.00132	CcSEcCtD
Alpha-Linolenic Acid—Rash—Alitretinoin—hematologic cancer	0.000172	0.00131	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Alitretinoin—hematologic cancer	0.000172	0.00131	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Ifosfamide—hematologic cancer	0.000171	0.00131	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Triamcinolone—hematologic cancer	0.00017	0.0013	CcSEcCtD
Alpha-Linolenic Acid—Rash—Ifosfamide—hematologic cancer	0.00017	0.0013	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Ifosfamide—hematologic cancer	0.00017	0.00129	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Vincristine—hematologic cancer	0.000167	0.00127	CcSEcCtD
Alpha-Linolenic Acid—Rash—Vincristine—hematologic cancer	0.000165	0.00126	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Vincristine—hematologic cancer	0.000165	0.00126	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Mitoxantrone—hematologic cancer	0.000162	0.00124	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Irinotecan—hematologic cancer	0.000162	0.00124	CcSEcCtD
Alpha-Linolenic Acid—Rash—Irinotecan—hematologic cancer	0.000161	0.00123	CcSEcCtD
Alpha-Linolenic Acid—Rash—Mitoxantrone—hematologic cancer	0.000161	0.00123	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Mitoxantrone—hematologic cancer	0.000161	0.00123	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Irinotecan—hematologic cancer	0.000161	0.00123	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.00016	0.00148	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MTAP—hematologic cancer	0.000159	0.00147	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Gemcitabine—hematologic cancer	0.000158	0.00121	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Ectoderm Differentiation—MYC—hematologic cancer	0.000158	0.00146	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—FOS—hematologic cancer	0.000157	0.00145	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—CREB1—hematologic cancer	0.000157	0.00145	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Gemcitabine—hematologic cancer	0.000157	0.0012	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Gemcitabine—hematologic cancer	0.000157	0.0012	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Methotrexate—hematologic cancer	0.000156	0.00119	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.000155	0.00144	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ARNTL—hematologic cancer	0.000155	0.00143	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HDC—hematologic cancer	0.000155	0.00143	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Dexamethasone—hematologic cancer	0.000154	0.00118	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Betamethasone—hematologic cancer	0.000154	0.00118	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—RAC2—hematologic cancer	0.000153	0.00142	CbGpPWpGaD
Alpha-Linolenic Acid—Dysgeusia—Methotrexate—hematologic cancer	0.000153	0.00117	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Prednisone—hematologic cancer	0.000152	0.00116	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000151	0.0014	CbGpPWpGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000151	0.00115	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000151	0.00115	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—ACP5—hematologic cancer	0.000151	0.00139	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CA9—hematologic cancer	0.000151	0.00139	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Etoposide—hematologic cancer	0.00015	0.00115	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOR2—hematologic cancer	0.000149	0.00137	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Cisplatin—hematologic cancer	0.000148	0.00113	CcSEcCtD
Alpha-Linolenic Acid—Rash—Cisplatin—hematologic cancer	0.000146	0.00112	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	0.000146	0.00135	CbGpPWpGaD
Alpha-Linolenic Acid—Dermatitis—Cisplatin—hematologic cancer	0.000146	0.00112	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000146	0.00135	CbGpPWpGaD
Alpha-Linolenic Acid—Malnutrition—Epirubicin—hematologic cancer	0.000146	0.00111	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.000144	0.00133	CbGpPWpGaD
Alpha-Linolenic Acid—Dysgeusia—Epirubicin—hematologic cancer	0.000143	0.00109	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—CDA—hematologic cancer	0.000142	0.00131	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—IDH1—hematologic cancer	0.000142	0.00131	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—FHL2—hematologic cancer	0.000142	0.00131	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—TXN—hematologic cancer	0.00014	0.00129	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ABCC3—hematologic cancer	0.00014	0.00129	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTO1—hematologic cancer	0.00014	0.00129	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AGRN—hematologic cancer	0.000139	0.00128	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SH2B3—hematologic cancer	0.000139	0.00128	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000138	0.00128	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—SPHK1—hematologic cancer	0.000137	0.00127	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Triamcinolone—hematologic cancer	0.000136	0.00104	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—PC—hematologic cancer	0.000136	0.00126	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Etoposide—hematologic cancer	0.000135	0.00103	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Doxorubicin—hematologic cancer	0.000135	0.00103	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Prednisone—hematologic cancer	0.000134	0.00102	CcSEcCtD
Alpha-Linolenic Acid—Rash—Etoposide—hematologic cancer	0.000134	0.00102	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Etoposide—hematologic cancer	0.000134	0.00102	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000134	0.00123	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SPARC—hematologic cancer	0.000132	0.00122	CbGpPWpGaD
Alpha-Linolenic Acid—Dysgeusia—Doxorubicin—hematologic cancer	0.000132	0.00101	CcSEcCtD
Alpha-Linolenic Acid—Rash—Prednisolone—hematologic cancer	0.000132	0.00101	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Prednisolone—hematologic cancer	0.000132	0.00101	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—UGT1A1—hematologic cancer	0.000132	0.00122	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SLC35B2—hematologic cancer	0.000132	0.00122	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GBA—hematologic cancer	0.000132	0.00122	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—IDH2—hematologic cancer	0.000132	0.00122	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—HMMR—hematologic cancer	0.000132	0.00122	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000131	0.00121	CbGpPWpGaD
Alpha-Linolenic Acid—Constipation—Prednisone—hematologic cancer	0.00013	0.000995	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—LCK—hematologic cancer	0.000128	0.00118	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—SLC22A1—hematologic cancer	0.000128	0.00118	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CRABP1—hematologic cancer	0.000128	0.00118	CbGpPWpGaD
Alpha-Linolenic Acid—Anaphylactic shock—Methotrexate—hematologic cancer	0.000127	0.000972	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000127	0.00117	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000126	0.00116	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000126	0.00116	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—H3F3A—hematologic cancer	0.000126	0.00116	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ALOX5—hematologic cancer	0.000125	0.00115	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—GATA3—hematologic cancer	0.000124	0.00115	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.000124	0.00115	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—HSPA5—hematologic cancer	0.000124	0.00114	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ARNTL—hematologic cancer	0.000124	0.00114	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Dexamethasone—hematologic cancer	0.000124	0.000945	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Betamethasone—hematologic cancer	0.000124	0.000945	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000123	0.00114	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Triamcinolone—hematologic cancer	0.000123	0.000936	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000122	0.00113	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PRKCZ—hematologic cancer	0.000122	0.00113	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Triamcinolone—hematologic cancer	0.000122	0.000928	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000121	0.00112	CbGpPWpGaD
Alpha-Linolenic Acid—Dermatitis—Triamcinolone—hematologic cancer	0.000121	0.000927	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—NUP98—hematologic cancer	0.000121	0.00112	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ACP5—hematologic cancer	0.00012	0.00111	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—MTAP—hematologic cancer	0.00012	0.00111	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CA9—hematologic cancer	0.00012	0.00111	CbGpPWpGaD
Alpha-Linolenic Acid—Anaphylactic shock—Epirubicin—hematologic cancer	0.000119	0.00091	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000119	0.0011	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOR2—hematologic cancer	0.000119	0.0011	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOA3—hematologic cancer	0.000117	0.00108	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ADCY7—hematologic cancer	0.000117	0.00108	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL1B—hematologic cancer	0.000117	0.00108	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NUP214—hematologic cancer	0.000117	0.00108	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.000115	0.00107	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—MTR—hematologic cancer	0.000114	0.00106	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ABCG2—hematologic cancer	0.000114	0.00106	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—HDAC2—hematologic cancer	0.000114	0.00105	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—IDH1—hematologic cancer	0.000113	0.00105	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—JUN—hematologic cancer	0.000113	0.00104	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CD44—hematologic cancer	0.000113	0.00104	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ITGA4—hematologic cancer	0.000113	0.00104	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Methotrexate—hematologic cancer	0.000112	0.000856	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—TXN—hematologic cancer	0.000112	0.00103	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ABCC3—hematologic cancer	0.000112	0.00103	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ENO2—hematologic cancer	0.000112	0.00103	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTO1—hematologic cancer	0.000112	0.00103	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Dexamethasone—hematologic cancer	0.000111	0.000849	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Betamethasone—hematologic cancer	0.000111	0.000849	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	0.000111	0.00102	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Dexamethasone—hematologic cancer	0.00011	0.000842	CcSEcCtD
Alpha-Linolenic Acid—Rash—Betamethasone—hematologic cancer	0.00011	0.000842	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Doxorubicin—hematologic cancer	0.00011	0.000842	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Dexamethasone—hematologic cancer	0.00011	0.000841	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Betamethasone—hematologic cancer	0.00011	0.000841	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.00011	0.000839	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00011	0.00102	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IL3—hematologic cancer	0.00011	0.00101	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SPHK1—hematologic cancer	0.00011	0.00101	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IFNA1—hematologic cancer	0.000109	0.00101	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTT1—hematologic cancer	0.000109	0.001	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PTPN1—hematologic cancer	0.000108	0.000997	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Prednisone—hematologic cancer	0.000108	0.000823	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—FHL2—hematologic cancer	0.000107	0.000992	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000107	0.000988	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—RASGRP1—hematologic cancer	0.000106	0.000981	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—SDC1—hematologic cancer	0.000106	0.000981	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000106	0.000981	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SYK—hematologic cancer	0.000106	0.000978	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AGRN—hematologic cancer	0.000105	0.000973	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—UGT1A1—hematologic cancer	0.000105	0.000973	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Epirubicin—hematologic cancer	0.000105	0.000801	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000103	0.000785	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CRABP1—hematologic cancer	0.000102	0.000946	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SLC22A1—hematologic cancer	0.000102	0.000946	CbGpPWpGaD
Alpha-Linolenic Acid—Constipation—Epirubicin—hematologic cancer	0.000102	0.000778	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IFNA2—hematologic cancer	0.000101	0.000938	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.000101	0.000937	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.0001	0.000925	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ALOX5—hematologic cancer	9.98e-05	0.000922	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—IDH2—hematologic cancer	9.98e-05	0.000922	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HMMR—hematologic cancer	9.98e-05	0.000922	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Doxorubicin—hematologic cancer	9.71e-05	0.000741	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Prednisone—hematologic cancer	9.69e-05	0.00074	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NUP98—hematologic cancer	9.66e-05	0.000893	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Prednisone—hematologic cancer	9.61e-05	0.000733	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Prednisone—hematologic cancer	9.6e-05	0.000733	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.57e-05	0.000885	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—GRB2—hematologic cancer	9.55e-05	0.000882	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PDGFA—hematologic cancer	9.52e-05	0.00088	CbGpPWpGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.52e-05	0.000727	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	9.47e-05	0.000875	CbGpPWpGaD
Alpha-Linolenic Acid—Constipation—Doxorubicin—hematologic cancer	9.43e-05	0.00072	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.41e-05	0.00087	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ARNTL—hematologic cancer	9.38e-05	0.000867	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOA3—hematologic cancer	9.38e-05	0.000867	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ADCY7—hematologic cancer	9.38e-05	0.000867	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NUP214—hematologic cancer	9.32e-05	0.000861	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.22e-05	0.000852	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.22e-05	0.000852	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ABL1—hematologic cancer	9.17e-05	0.000848	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CA9—hematologic cancer	9.13e-05	0.000844	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MTR—hematologic cancer	9.13e-05	0.000844	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ACP5—hematologic cancer	9.13e-05	0.000844	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ABCG2—hematologic cancer	9.13e-05	0.000844	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NQO1—hematologic cancer	9.02e-05	0.000834	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CD44—hematologic cancer	9.02e-05	0.000834	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Methotrexate—hematologic cancer	9.01e-05	0.000688	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOR2—hematologic cancer	9.01e-05	0.000833	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ENO2—hematologic cancer	8.95e-05	0.000827	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.9e-05	0.000823	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.84e-05	0.000817	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTT1—hematologic cancer	8.68e-05	0.000802	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—HGF—hematologic cancer	8.63e-05	0.000797	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—IDH1—hematologic cancer	8.58e-05	0.000793	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.55e-05	0.00079	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYCS—hematologic cancer	8.54e-05	0.000789	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CSF2—hematologic cancer	8.53e-05	0.000788	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SDC1—hematologic cancer	8.48e-05	0.000784	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—TXN—hematologic cancer	8.48e-05	0.000784	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTO1—hematologic cancer	8.48e-05	0.000784	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—HSP90AA1—hematologic cancer	8.48e-05	0.000784	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ABCC3—hematologic cancer	8.48e-05	0.000784	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Epirubicin—hematologic cancer	8.43e-05	0.000644	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—SPHK1—hematologic cancer	8.3e-05	0.000767	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—JAK1—hematologic cancer	8.23e-05	0.000761	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PRKCG—hematologic cancer	8.23e-05	0.000761	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.1e-05	0.000749	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Methotrexate—hematologic cancer	8.1e-05	0.000618	CcSEcCtD
Alpha-Linolenic Acid—Rash—Methotrexate—hematologic cancer	8.03e-05	0.000613	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Methotrexate—hematologic cancer	8.02e-05	0.000612	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8e-05	0.000739	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—UGT1A1—hematologic cancer	7.98e-05	0.000737	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Doxorubicin—hematologic cancer	7.8e-05	0.000596	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—SLC22A1—hematologic cancer	7.76e-05	0.000717	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CRABP1—hematologic cancer	7.76e-05	0.000717	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.69e-05	0.000711	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IL2RA—hematologic cancer	7.69e-05	0.000711	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.65e-05	0.000707	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.64e-05	0.000706	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Epirubicin—hematologic cancer	7.58e-05	0.000578	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—ALOX5—hematologic cancer	7.56e-05	0.000699	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTP1—hematologic cancer	7.53e-05	0.000696	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Epirubicin—hematologic cancer	7.51e-05	0.000574	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Epirubicin—hematologic cancer	7.51e-05	0.000573	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.43e-05	0.000687	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PDGFB—hematologic cancer	7.42e-05	0.000686	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NUP98—hematologic cancer	7.32e-05	0.000677	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.28e-05	0.000673	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CD44—hematologic cancer	7.21e-05	0.000667	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NQO1—hematologic cancer	7.21e-05	0.000667	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CDK2—hematologic cancer	7.2e-05	0.000665	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ABCB1—hematologic cancer	7.12e-05	0.000659	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ADCY7—hematologic cancer	7.11e-05	0.000657	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOA3—hematologic cancer	7.11e-05	0.000657	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.06e-05	0.000653	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NUP214—hematologic cancer	7.06e-05	0.000653	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Doxorubicin—hematologic cancer	7.01e-05	0.000535	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.99e-05	0.000646	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Doxorubicin—hematologic cancer	6.95e-05	0.000531	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Doxorubicin—hematologic cancer	6.95e-05	0.00053	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—MTR—hematologic cancer	6.92e-05	0.000639	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ABCG2—hematologic cancer	6.92e-05	0.000639	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTM1—hematologic cancer	6.92e-05	0.000639	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOR1—hematologic cancer	6.92e-05	0.000639	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—MAPK14—hematologic cancer	6.91e-05	0.000638	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL6—hematologic cancer	6.83e-05	0.000631	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYCS—hematologic cancer	6.83e-05	0.000631	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ENO2—hematologic cancer	6.78e-05	0.000627	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—HSP90AA1—hematologic cancer	6.78e-05	0.000627	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—FN1—hematologic cancer	6.69e-05	0.000619	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTT1—hematologic cancer	6.58e-05	0.000608	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.48e-05	0.000599	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SDC1—hematologic cancer	6.43e-05	0.000594	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CG—hematologic cancer	6.4e-05	0.000592	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PTPN11—hematologic cancer	6.29e-05	0.000582	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.14e-05	0.000568	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—MTHFR—hematologic cancer	6.11e-05	0.000565	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.1e-05	0.000564	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.06e-05	0.00056	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTP1—hematologic cancer	6.02e-05	0.000556	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CREBBP—hematologic cancer	5.94e-05	0.000549	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.82e-05	0.000538	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.8e-05	0.000536	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ABCB1—hematologic cancer	5.7e-05	0.000526	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CD—hematologic cancer	5.63e-05	0.00052	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ALB—hematologic cancer	5.56e-05	0.000514	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTM1—hematologic cancer	5.53e-05	0.000511	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOR1—hematologic cancer	5.53e-05	0.000511	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NQO1—hematologic cancer	5.47e-05	0.000505	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CD44—hematologic cancer	5.47e-05	0.000505	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.39e-05	0.000498	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.35e-05	0.000495	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3R1—hematologic cancer	5.32e-05	0.000491	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYCS—hematologic cancer	5.17e-05	0.000478	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—JAK2—hematologic cancer	5.17e-05	0.000478	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.14e-05	0.000475	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HSP90AA1—hematologic cancer	5.14e-05	0.000475	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CG—hematologic cancer	5.14e-05	0.000475	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.96e-05	0.000459	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CB—hematologic cancer	4.91e-05	0.000454	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MTHFR—hematologic cancer	4.89e-05	0.000452	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.81e-05	0.000445	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CREBBP—hematologic cancer	4.76e-05	0.00044	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.65e-05	0.00043	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.63e-05	0.000428	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTP1—hematologic cancer	4.56e-05	0.000421	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CD—hematologic cancer	4.51e-05	0.000417	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IL2—hematologic cancer	4.51e-05	0.000417	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ALB—hematologic cancer	4.46e-05	0.000412	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.41e-05	0.000408	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ABCB1—hematologic cancer	4.32e-05	0.000399	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.31e-05	0.000398	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3R1—hematologic cancer	4.26e-05	0.000394	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTM1—hematologic cancer	4.19e-05	0.000387	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOR1—hematologic cancer	4.19e-05	0.000387	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CG—hematologic cancer	4.11e-05	0.000379	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—EP300—hematologic cancer	4.04e-05	0.000374	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CB—hematologic cancer	3.94e-05	0.000364	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SRC—hematologic cancer	3.93e-05	0.000364	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—VEGFA—hematologic cancer	3.83e-05	0.000354	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CREBBP—hematologic cancer	3.81e-05	0.000352	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—NRAS—hematologic cancer	3.78e-05	0.00035	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—MTHFR—hematologic cancer	3.7e-05	0.000342	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—MAPK3—hematologic cancer	3.62e-05	0.000335	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CD—hematologic cancer	3.61e-05	0.000334	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ALB—hematologic cancer	3.56e-05	0.000329	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—TGFB1—hematologic cancer	3.52e-05	0.000325	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3R1—hematologic cancer	3.41e-05	0.000315	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PTEN—hematologic cancer	3.4e-05	0.000314	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.26e-05	0.000302	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—KRAS—hematologic cancer	3.26e-05	0.000301	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—EP300—hematologic cancer	3.24e-05	0.0003	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CB—hematologic cancer	3.15e-05	0.000291	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CG—hematologic cancer	3.11e-05	0.000288	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CA—hematologic cancer	2.99e-05	0.000277	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—TP53—hematologic cancer	2.89e-05	0.000268	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CREBBP—hematologic cancer	2.88e-05	0.000267	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—HRAS—hematologic cancer	2.77e-05	0.000256	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CD—hematologic cancer	2.74e-05	0.000253	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PTEN—hematologic cancer	2.72e-05	0.000251	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ALB—hematologic cancer	2.7e-05	0.00025	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—EP300—hematologic cancer	2.59e-05	0.00024	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3R1—hematologic cancer	2.58e-05	0.000239	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—AKT1—hematologic cancer	2.44e-05	0.000226	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CA—hematologic cancer	2.4e-05	0.000222	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CB—hematologic cancer	2.38e-05	0.00022	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PTEN—hematologic cancer	2.06e-05	0.00019	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—EP300—hematologic cancer	1.96e-05	0.000182	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—AKT1—hematologic cancer	1.96e-05	0.000181	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CA—hematologic cancer	1.92e-05	0.000177	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AKT1—hematologic cancer	1.57e-05	0.000145	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CA—hematologic cancer	1.45e-05	0.000134	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AKT1—hematologic cancer	1.19e-05	0.00011	CbGpPWpGaD
